Clinical Trial Update: Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF [Phase 2, Phase 3]

View source ↗

Summary

A multi-phase clinical trial evaluating Conbercept for refractory uveitic macular edema has been terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Uveitis

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Uveitis, Macular Edema | Phase 2, Phase 3 | Status: TERMINATED